<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>457</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15503212</PubmedId>
            <Abstract>The nucleoproteins (NP) of a group of influenza A virus strains were analyzed with the use of a panel of anti-NP monoclonal antibodies (Mabs) in the radioimmunosorbtion reaction with subsequent polyacrylamide gel electrophoresis of the immune complexes, and in the immunoblotting. The group included 2 pairs of closely related viruses having minimal amino acid differences in NP sequence. The analysis of the results of the immune reactions in comparison with the known amino acid sequences of NP allowed us to suggest that the Mab 150/4 recognizes the epitope containing amino acid residues in positions 196 and/or 290, whereas the amino acid residue in position 353 participates in the formation of the antigenic epitope reacting with the Mab 7/3.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>2271-6</ArticlePages>
            <ArticleTitle>Antigenically relevant amino acid positions as revealed by reactions of monoclonal antibodies with the nucleoproteins of closely related influenza A virus strains.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Varich</LastName>
                    <ForeName>N L</ForeName>
                </Author>
                <Author>
                    <LastName>Kaverin</LastName>
                    <ForeName>N V</ForeName>
                </Author>
            </Authors>
            <Affiliations>The D. I. Ivanovsky Institute of Virology RAMS, Moscow, Russia.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Epitopes;NP protein, Influenza A virus;Nucleoproteins;RNA-Binding Proteins;Viral Core Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Monoclonal(immunology); Cell Line; Dogs; Enzyme-Linked Immunosorbent Assay; Epitopes; Nucleoproteins(chemistry; immunology); RNA-Binding Proteins(chemistry; immunology); Viral Core Proteins(chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>149</Volume>
                <Issue>11</Issue>
                <Title>Archives of virology</Title>
                <Issn>1432-8798</Issn>
                <MedlineTa>Arch Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Epitope of mAb 7/3 on NP</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>V353</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>AAA43467.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>385600</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>149577</EpitopeId>
                <ReferenceRegion>V353</ReferenceRegion>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope was deduced.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1, tables 1 and 2</LocationOfData>
                        <BCellId>1850196</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>382835</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus (A/WSN/33(H1N1))</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <DoseSchedule>3 doses of either 500 µg of purified virus or with 0.5 ml of a lung suspension from WSN-infected BALB/c mice.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The mAb was generated from spleen cells of mice hyperimmunized with either purified WSN virus or with a lung suspension from WSN-infected BALB/c mice and fused with the 8-azaquanine-resistant clone of MOPC-21 myeloma cells (P3/X63-Ag8). The details of the immunization procedure were described in the cited reference: van Wyke KL, et al. 1980. J Virol 35: 24–30. [PMID: 6157838].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>39</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was deduced by loss of recognition of nucleoproteins from influenza A virus strains with sequence difference. MAb 7/3 did not react with NP from strains PR/8/34-Mt.Sin, USSR/77 or Brazil/78 which have a substitution of L/I at position V353.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Mab 7/3</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA43467.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>385600</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Epitope of mAb 150/4 on NP</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>M53, D147</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>AAG41965.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>382835</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>149584</EpitopeId>
                <ReferenceRegion>M196, D290</ReferenceRegion>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope was deduced.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1, tables 1 and 2</LocationOfData>
                        <BCellId>1850210</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>382835</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus (A/WSN/33(H1N1))</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <DoseSchedule>3 doses of either 500 µg of purified virus or with 0.5 ml of a lung suspension from WSN-infected BALB/c mice.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The mAb was generated from spleen cells of mice hyperimmunized with either purified WSN virus or with a lung suspension from WSN-infected BALB/c mice and fused with the 8-azaquanine-resistant clone of MOPC-21 myeloma cells (P3/X63-Ag8). The details of the immunization procedure were described in the cited reference: van Wyke KL, et al. 1980. J Virol 35: 24–30. [PMID: 6157838].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>39</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was deduced by loss of recognition of nucleoproteins from influenza virus strains with sequence difference. MAb 150/4 did not react with NP from strain Brazil/78 which has substitutions M196L and D290A. MAb 150/4 did react with strain USSR/77 with substitution D290E.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Mab 150/4</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAG41965.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>382835</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

